HomeBUSINESS
BUSINESS

ASKA Expands Testosterone Deal with TesoRx Pharma
(Dec.5.2017)

ASKA Pharmaceutical has added Southeast Asia to the territory of its exclusive licensing deal with TesoRx Pharma on the US firm’s oral testosterone replacement therapy TSX-011 (previous development code: THG-1001) in Japan, the two companies said on December 1 ...
(LOG IN FOR FULL STORY)

News Calendar